Author

P. Carter

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:clustering· 1

Frequent Co-Authors

A. Thomas· 2 shared D. Roame· 2 shared L. Pongor· 2 shared N. Takahashi· 2 shared P. Desai· 2 shared S. Nichols· 2 shared W. D. Figg· 2 shared A. Ditsiou· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Thomas

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genomic alterations and transcriptional phenotypes in circulating tumor DNA and matched metastatic tumor

N. Takahashi, L. Pongor, S. P. Agrawal, M. Shtumpf, V. N. Rajapakse, A. Shafiei, C. W. Schultz, S. Kim, D. Roame, P. Carter, R. Vilimas, S. Nichols, P. Desai, W. D. Figg, M. Bagheri, , A. Thomas

This study compares genomic alterations and transcriptional phenotypes in circulating tumor DNA and matched metastatic tumors in SCLC patients, finding cfDNA reflects tumor mutations, identifies resistance mechanisms, and tracks tumor evolution.

bioRxiv · Jun 2, 2024 · PreprintCancer Biology

Subtyping of Small Cell Lung Cancer using plasma cell-free nucleosomes

G. Fialkoff, N. Takahashi, I. Sharkia, J. Gutin, N. Hermoni, R. Kumar, L. Pongor, S. Nichols, L. Sciuto, C. Graham, P. Desai, M. Nirula, P. Suresh, M. Abel, R. Elmeskini, , A. Thomas

This study uses cfChIP-seq on plasma samples to subtype SCLC based on epigenetic states, linking plasma nucleosome data to tumor transcriptomes and developing a classifier for lineage-defining transcription factors.

bioRxiv · Jun 24, 2022 · PreprintCancer Biology

Global kinome silencing combined with 3D invasion screening of the tumor microenvironment identifies fibroblast-expressed PIK3Cδ involvement in triple-negative breast cancer progression

T. Gagliano, K. Shah, S. Gargani, L. Lao, M. Alsaleem, J. Chen, V. Ntafis, P. Huang, A. Ditsiou, V. Vella, K. Yadav, K. Bienkowska, G. Bresciani, K. Kang, L. Li, , G. Giamas

The paper identifies fibroblast-expressed PIK3Cδ as a key driver of triple-negative breast cancer progression through paracrine signaling and shows its prognostic significance.

bioRxiv · Nov 2, 2019 · PreprintCancer Biology